Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Carenini

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Biochemical Pharmacology|January 24, 1997
Physicochemical properties, cytotoxic activity and topoisomerase II inhibition of 2,3-diaza-anthracenedionesP de Isabella, M Palumbo, C Sissi, et al.
Biochemical Pharmacology|August 27, 1998
Decreased drug accumulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistanceC Lanzi, P Perego, R Supino, et al.
Molecular Pharmacology|March 3, 1999
A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell systemP Perego, C Caserini, L Gatti, et al.
Cancer Research|August 17, 2001
A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell lineP Perego, M De Cesare, P De Isabella, et al.
Cancer Research|October 5, 2001
Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecinM De Cesare, G Pratesi, P Perego, et al.
Journal of Medicinal Chemistry|September 21, 2001
Novel 7-oxyiminomethyl derivatives of camptothecin with potent in vitro and in vivo antitumor activityS Dallavalle, A Ferrari, B Biasotti, et al.
Oncology|September 28, 2001
A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenograftsR Supino, D Polizzi, R Pavesi, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Biochemical Pharmacology|January 24, 1997
Physicochemical properties, cytotoxic activity and topoisomerase II inhibition of 2,3-diaza-anthracenedionesP de Isabella, M Palumbo, C Sissi, et al.
Biochemical Pharmacology|August 27, 1998
Decreased drug accumulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistanceC Lanzi, P Perego, R Supino, et al.
Molecular Pharmacology|March 3, 1999
A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell systemP Perego, C Caserini, L Gatti, et al.
Cancer Research|August 17, 2001
A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell lineP Perego, M De Cesare, P De Isabella, et al.
Cancer Research|October 5, 2001
Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecinM De Cesare, G Pratesi, P Perego, et al.
Journal of Medicinal Chemistry|September 21, 2001
Novel 7-oxyiminomethyl derivatives of camptothecin with potent in vitro and in vivo antitumor activityS Dallavalle, A Ferrari, B Biasotti, et al.
Oncology|September 28, 2001
A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenograftsR Supino, D Polizzi, R Pavesi, et al.
Pageof 3